Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.68 USD | -0.20% |
|
+2.51% | -12.88% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.88% | 946M | |
+17.49% | 124B | |
+18.72% | 112B | |
+3.81% | 22.94B | |
-11.24% | 17.02B | |
-16.59% | 16.88B | |
-39.94% | 16.87B | |
+3.11% | 13.63B | |
+25.86% | 11.61B | |
+105.68% | 10.31B |
- Stock Market
- Equities
- SAVA Stock
- News Cassava Sciences, Inc.
- Cassava Sciences : B. Riley Raises Cassava Sciences' PT to $111 from $78 on Regulatory Tailwinds for Late-Stage AD Therapeutic, Keeps Buy Rating